Thank you for your interest and concern regarding the recent FDA assertion on restricting access to Bioidentical Hormone Replacement Therapies (BHRT).  We are currently investigating this situation and disagree whole-heartedly with the FDA's position.  Preserving access to BHRT is crucial to meeting the health needs of our customers and we will continue to provide your medication(s) as status quo.  As more news becomes available, we will update you through our website, so please check back periodically.

Again, thank you.